A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Conditions: Healthy; Obese; Overweight Interventions: Drug: Orforglipron; Drug: Simvastatin; Drug: Digoxin; Drug: Rosuvastatin; Drug: Acetaminophen; Drug: Midazolam; Drug: Sodium Bicarbonate Sponsors: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials